Global Radiation Dose Management Market Driven by Rising Demand for Minimally Invasive Procedures

In the past two decades, there has been a significant increase in radiation exposure to patients due to the growing use of diagnostic tests like CT scans, fluoroscopy, and interventional imaging procedures. The global radiation dose management market is expected to experience impressive growth in the coming years, driven by factors such as the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and heightened awareness of radiation dose management.

These are the latest findings of Research and Markets (Dublin, Ireland), a leading source for market research reports.

The robust growth of the global radiation dose management market can also be attributed to the increasing demand for patient safety, strict federal and state regulations, obligations for healthcare providers, and the expanding healthcare infrastructure in developing regions. Moreover, advancements in radiation devices and the growing adoption of radiation dose management by patients and healthcare providers will serve as key growth drivers for the market in the future.

Additionally, the rising prevalence of cancer is anticipated to fuel the growth of the global radiation dose management market. Cancer is the second leading cause of death worldwide and is growing rapidly due to factors such as alcohol consumption, excessive smoking, and unhealthy lifestyles. Interventional oncology devices are used for cancer diagnosis and treatment, as well as for assisting surgeons in developing appropriate treatment plans. The swift adoption of new technology can increase the demand for interventional oncology devices, driving the growth of the global radiation dose management market. The growing demand for minimally invasive surgeries is also expected to contribute significantly to market growth.

Regionally, North America dominates the global radiation dose management market, with the U.S. accounting for a major share of the North American market. This is due to the rising demand for minimally invasive surgeries and the low cost of chronic disease treatments, such as cancer, in the country.

Related Links:
Research and Markets

Visit expo >

Biopsy Software

Affirm® Contrast

X-ray Diagnostic System

FDX Visionary-A

Ultrasound Imaging System

P12 Elite

Digital Radiographic System

OMNERA 300M